Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.

NCT01691391 · clinicaltrials.gov ↗

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BEHAVIORAL: (Early) Imaging of response with [18F-]-FDG PET-CT and kinase activity profiles

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]